Flc Capital Advisors Regeneron Pharmaceuticals, Inc. Transaction History

Flc Capital Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 25, 2022	SELL	$595.12 - $698.43 $191,033 - $224,196	-321 Closed	0 $0
Q4 2021 Jan 26, 2022	SELL	$543.48 - $670.97 $163,044 - $201,291	-300 Reduced 48.31%	321 $203,000
Q3 2021 Oct 13, 2021	SELL	$574.03 - $680.96 $35,589 - $42,219	-62 Reduced 9.08%	621 $376,000
Q1 2021 Apr 23, 2021	BUY	$446.73 - $548.2 $305,116 - $374,420	683 New	683 $323,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Flc Capital Advisors, based on Form 13F filings with the SEC.

Stay updated on Flc Capital Advisors with notifications on news.